Founder & CEO

Dr. Amit DangDr. Amit Dang is the founder and CEO of MarksMan Healthcare Solutions.

He completed his M.D. (Doctor of Medicine) in Pharmacology from Goa Medical College and was the recipient of “Baba Saheb Ambedkar Award” (2010) for being the university topper. “Being the winner of national “Uppsala Award” (2008) from Society of Pharmacovigilance, India (SOPI), recipient of “Indian Leadership Award for Healthcare Excellence” (2013) from “All India Achievers Foundation”, “Healthcare Entrepreneur of the Year” (2015) from “The Indus Foundation”, “Young Global leader Award” (2017) from “Global Leaders Foundation” and currently having over 30 publications to his credit in various national and international journals, Dr. Dang has always worked towards providing value-added support to the client’s business in driving the strategies through scientific & ethical approach.”

He is the convener for INMAS (Indian Medical Advisors Summit), which is first of its kind initiative that has been undertaken in India for the cause of Medical Affairs personnel to interact learn, share new ideas, best practices & case studies amongst this evolving community (Express Pharma). He has also been featured in “YourStory”, India’s no. 1 media platform for entrepreneurs, dedicated to passionately championing and promoting the entrepreneurial ecosystem in India. He is the president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR India – Mumbai Regional Chapter) and also the executive committee member of ISPOR – India Chapter. He is currently taking active part in the changing paradigm of HEOR in the Indian context.

Dr. Amit Dang has set up MarksMan Healthcare Solutions, the first Indian born health economics consulting firm, with a goal to support pharmaceutical companies in demonstrating clinical and economic effectiveness of their products to gain market access and remain competitive in this dynamic field.

Our Strengths

Quality

  • Well-defined workflow SOPs
  • Stringent proof reading and quality reviews
  • Quality assurance and control

Confidentiality

  • Secure communication system
  • Strict document privacy
  • Assured data confidentiality

Timelines

  • Efficient project management
  • Low turnaround time
  • On-time delivery

Rich Talent Pool

  • Professional medical writers
  • Highly qualified workforce
  • Experienced reviewers quality

Publications

  1. Dang A, Kanukula R, Shah C, Shetye V. The Emerging Role of Patient Reported Outcomes (PROs) in Clinical Trials: An Indian Perspective. Value in Health 2017; 12:24-26
  2. Dang A, Vallish B N. Patient Advocacy and Changing Paradigm in Drug Access. Int J Med Public Health 2016;6:179-18
  3. Dang A, Vallish B N. Real world evidence: An Indian perspective. Perspect Clin Res 2016;7:156-60
  4. Dang A, Vallish B N. Can Health Technology Assessment (HTA) provide a solution to tackle the increasing health-care expenditure in India?. Indian J Public Health 2016;60:138-41
  5. Kaur R, Kachroo K, Sharma JK, Vatturi SM, Dang A. Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and meta-analysis. J Global Infect Dis 2016;8:32-40
  6. Dang A, Manjunath T A. The value of observational study data in healthcare decision making: An Indian perspective. Int J Med Public Health 2016;6:53-5
  7. Dang A, Likhar N, Alok U. Importance of Economic Evaluation in Health Care: An Indian Perspective. Value in Health Regional Issues. 2016;9:78-83
  8. Dang A, Kaur K. Comparative effectiveness research and its utility in In-clinic practice. Perspect Clin Res 2016;7:9-14
  9. Dang A, Angle VS. Utilizing Patient Registries as Health Technology Assessment (HTA) tool. Sys Rev Pharm 2015, 6 (1):5-8
  10. Dang A, Mendon S. The Role of Patient Reported Outcomes (PROs) in Healthcare Policy Making. Sys Rev Pharm 2015, 6 (1):1-5
  11. Dang A, Mendon S, Desireddy P. Improving Access to New Treatments with Value Based Pricing: An Indian Perspective. Pharmacology, Toxicology and Biomedical Reports. 2016;2(1):1-5
  12. Dang A, Angle V Shetye. Stratified Medicine: Will it be the Future of Medicine? Pharmacology, Toxicology and Biomedical Reports. 2016;2(1):11-14.
  13. Chaudhary T, Chahar A, Sharma JK, Kaur K, Dang A. Phytomedicine in the Treatment of Cancer: A Health Technology Assessment. Journal of Clinical and Diagnostic Research [serial online] 2015 December [cited: 2015 Dec 7 ]; 9:XC04-XC09.
  14. Kaur K, Likar N, Dang A, Kaur G. Efficacy and safety of canagliflozin among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Indian J Endocr Metab 2015;19:705-21
  15. Dang A, Mendon S. The Value of Big Data in Clinical Decision Making. International Journal of Computer Science and Information Technologies, Vol. 6 (4) , 2015, 3830-3835
  16. Dang A, Vallish B N. The emerging role of patient-centered outcomes research in shaping the future of healthcare delivery in India: A brief review. Int J Med Public Health 2015;5:125-7
  17. Dang A, Vallish B N. Role of a medical advisor in pharmacovigilance as a business support service. Perspect Clin Res 2015;6:64-7
  18. Dang A. Vallish BN. Electronic Health Record System in India: Implications for Health Technology Assessment (HTA), Status and Challenges. The Pharma Review 2014; 72-74
  19. Dang A, Garg A. Management of Clinical Trials in India – Current Perspective and Way Forward. The Pharma Review. 2013: 95-100
  20. Dang A, Bhandare PN. The profile of voluntary reported adverse drug reactions at a tertiary care hospital: a fifteen month prospective study. J Clin Diagn Res. 2012;6(9):1504-9
  21. Dang A, Garg A, Rataboli PV. Role of zolpidem in the management of insomnia. CNS Neurosci Ther. 2011;17(5):387-97
  22. Rahman SZ, Gupta V, Dang A, Sukhlecha A. Lifestyle drugs in India: are we ready for them? AMJ 2010, 1, 3, 186-189
  23. Afonso N, Rane P, Dang A, Rataboli PV and Goel H. Fluconazole induced herpes labialis like lesions in an adult male. AMJ 2009, 1, 14, 246-247
  24. Oberoi DV, Goraya H, Mungee A, Sharma S, Dang A, Agarwal K, Kulkarni T, Khatri D, Rajeev A. Unregulated Sale of Nimesulide in India. AMJ 2009, 1, 9, 78-81
  25. Afonso N, Dang A, Namshikar V, Kamat S, Rataboli PV. Intravenous ondansetron causing severe bradycardia: Two cases. Ann Card Anaesth. 2009;12(2):203-4
  26. Dang A, Garg A, Rataboli PV. Current Perspectives of Medical Pharmacology Post Graduates in India: Need to Commute the System. Journal of Clinical and Diagnostic Research [serial online] 2009; 3:1601-1602
  27. Dang A, Garg G, Rataboli PV. Zolpidem induced Nocturnal Sleep-Related Eating Disorder (NSRED) in a male patient. Int J Eat Disord. 2009;42(4):385-6
  28. Afonso N, Shetgaonkar P, Dang A, Rataboli PV. Cetirizine-induced anaphylaxis: a rare adverse drug reaction. Br J Clin Pharmacol. 2009;67(5):577-8
  29. Dang A, Garg G, Rataboli PV. Mirtazapine induced nightmares in an adult male. Br J Clin Pharmacol. 2009 ;67(1):135-6
  30. Amit D, Rataboli PV. Adverse drug reaction (ADR) notification drop box: an easy way to report ADRs. Br J Clin Pharmacol. 2008;66(5):723-4
  31. Dang A, Kamat R, Rataboli PV. Ciprofloxacin induced nightmares in an adult patient. Indian J Psychiatry 2008: 50(4): 305-6.
  32. De Sousa R, Dang A, Rataboli PV. Nicolau syndrome following intramuscular benzathine penicillin. J Postgrad Med. 2008;54(4):332-34
  33. Mudiganty SSP, Dang A, Rataboli PV. Crippled Pharmacovigilance: A Qualm of Medical Profession. Journal of Clinical and Diagnostic Research [serial online] 2008; 2:1110-1118
  34. Dang A, Kamat A, Rataboli PV, Dang S. Renin-angiotensin-aldosterone system (RAAS) block revisited. Natl Med J India. 2008;21(4):210
  35. Dang A, Dias A. Differences In Risk Factors And Mortality, In Young And Old Individuals With Acute Myocardial Infarction In Goa. Journal of Clinical and Diagnostic Research [serial online] 2008; 2:715-719
  36. Kare M, Dang S, Dang A. Rosai Dorfman syndrome with sinonasal mucosa and intraocular involvement. J Assoc Physicians India. 2007 ;55:448-50
  37. Rataboli P V, Dang A, Dang S. Selecting cost effective antimicrobials: quandary of medical profession. Journal of Clinical and Diagnostic Research [serial online] 2008 June; 2:806-814
  38. Rataboli PV, Dang A. Antimicrobial price variation: conundrum of medical profession. J Postgrad Med 2007; 53: 72-74